Treatment outcome and current status
Patient . | Months post-BMT . | GVH . | Lansky pre-BMT . | Score post-BMT . | Clinical status . |
---|---|---|---|---|---|
1 | 17 | N | 80 | 100 | Well |
2 | 16 | N | 50 | 100 | Well |
3 | 15 | N | 90 | 100 | Well |
4 | 3 | N | 70 | — | Relapse/died |
5 | 12 | N | 90 | 100 | Well/mixed chimera |
6 | 12 | N | 80 | 90 | Well |
7 | 11 | N | 80 | 100 | Well/mixed chimera |
8 | 8 | Y | 80 | 90 | Well |
Patient . | Months post-BMT . | GVH . | Lansky pre-BMT . | Score post-BMT . | Clinical status . |
---|---|---|---|---|---|
1 | 17 | N | 80 | 100 | Well |
2 | 16 | N | 50 | 100 | Well |
3 | 15 | N | 90 | 100 | Well |
4 | 3 | N | 70 | — | Relapse/died |
5 | 12 | N | 90 | 100 | Well/mixed chimera |
6 | 12 | N | 80 | 90 | Well |
7 | 11 | N | 80 | 100 | Well/mixed chimera |
8 | 8 | Y | 80 | 90 | Well |